Comparative Pharmacology

Head-to-head clinical analysis: DIANEAL LOW CALCIUM W DEXTROSE 3 5 IN PLASTIC CONTAINER versus DIANEAL PD 1 W DEXTROSE 1 5 IN PLASTIC CONTAINER.

Peer-Reviewed Evidence

Differential Analysis

DIANEAL LOW CALCIUM W/DEXTROSE 3.5% IN PLASTIC CONTAINER vs DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER

Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.

DIANEAL LOW CALCIUM W/DEXTROSE 3.5% IN PLASTIC CONTAINER

Peritoneal Dialysis Solution

Category C

DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER

Peritoneal Dialysis Solution

Category C

Head-to-Head

Clinical Matrix

Mechanism of Action

DIANEAL LOW CALCIUM W/DEXTROSE 3.5% provides a hyperosmotic solution for peritoneal dialysis. Dextrose generates an osmotic gradient across the peritoneal membrane, promoting fluid and solute removal (ultrafiltration). Low calcium content helps manage hypercalcemia in patients requiring peritoneal dialysis.

Dianeal PD-1 with Dextrose 1.5% is a peritoneal dialysis solution that uses dextrose as an osmotic agent to create a concentration gradient across the peritoneal membrane, facilitating the removal of waste products (e.g., urea, creatinine) and excess fluid from the blood into the peritoneal cavity via diffusion and ultrafiltration.

Clinical Dosing

Intraperitoneal: 2-3 L per exchange, 4-5 exchanges daily, as prescribed by physician based on body size and residual renal function.

2 L intraperitoneally via continuous ambulatory peritoneal dialysis (CAPD) four times daily, with dwell times of 4-6 hours each. For automated peritoneal dialysis (APD), 2 L per cycle with 4-5 cycles overnight.

Direct Interaction

None Documented